EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2

Hyeon-Min Cha, Uk-Il Kim, Soo Bin Ahn, Myoung Kyu Lee, Haemi Lee iD, Hyungtae Bang, Yejin Jang, Seong Soon Kim iD, Myung Ae Bae, Kyungjin Kim, Meehyein Kim iD

ACS Infectious Diseases · 14.04.2023 · 9 (4) · 1033-1045

DOI: 10.1021/acsinfecdis.3c00034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 13.03.2023. Verfasst von Hyeon-Min Cha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Orthomyxoviridae. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Korea Research Institute of Chemical Technology, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanCOVID-19OrthomyxoviridaeHumansAnimalsMiceAntiviral AgentsSARS-CoV-2GemcitabineNucleosides

Stichwörter der Autor:innen

SARS-CoV-2antiviral agentgemcitabine derivativesinfluenza viruspolymerase inhibitor

Substanzen

Antiviral AgentsGemcitabineNucleosides

Autor:innen und Institutionen

  • Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
  • Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
  • ST Pharm Co., Ltd., Seoul 06194, Republic of Korea.
  • College of Pharmacy, Dongguk University, Goyang-si, Gyeonggi-do 10326, Republic of Korea.
  • Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.

ORCID-Profile: Haemi Lee, Seong Soon Kim, Meehyein Kim

Förderung

  • Ministry of Health and Welfare
  • Korea Research Institute of Chemical Technology
  • National Research Foundation of Korea
  • ST Pharm Co.

Zitieren

APA

Cha, H. M., Kim, U. I., Ahn, S. B., Lee, M. K., Lee, H., Bang, H., Jang, Y., Kim, S. S., Bae, M. A., Kim, K., & Kim, M. (2023). Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2. ACS Infectious Diseases, 9(4), 1033-1045. https://doi.org/10.1021/acsinfecdis.3c00034

Vancouver

Cha HM, Kim UI, Ahn SB, Lee MK, Lee H, Bang H, et al. Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2. ACS Infectious Diseases. 2023;9(4):1033-1045. doi:10.1021/acsinfecdis.3c00034

BibTeX
@article{Cha2023,
  author = {Cha, Hyeon-Min and Kim, Uk-Il and Ahn, Soo Bin and Lee, Myoung Kyu and Lee, Haemi and Bang, Hyungtae and Jang, Yejin and Kim, Seong Soon and Bae, Myung Ae and Kim, Kyungjin and Kim, Meehyein},
  title = {Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2},
  journal = {ACS Infectious Diseases},
  year = {2023},
  volume = {9},
  number = {4},
  pages = {1033--1045},
  doi = {10.1021/acsinfecdis.3c00034}
}
Kostenlos starten →